Sofinnova Venture Partners X L.P. 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-20 8:56 pm Sale | 2023-06-14 | 13D | Karuna Therapeutics, Inc. KRTX | Sofinnova Venture Partners X L.P. | 1,439,649 3.800% | -386,975 (-21.19%) | Filing |
| 2023-02-03 7:11 pm Purchase | 2023-01-12 | 13D | Karuna Therapeutics, Inc. KRTX | Sofinnova Venture Partners X L.P. | 1,826,624 5.300% | 97,272 (+5.62%) | Filing |